← Back to Search

Behavioral Intervention

Digital CBT-I for Insomnia (SLEEP-BOOST Trial)

N/A
Waitlist Available
Led By Lei Gao, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Scheduled for an elective orthopedic total joint replacement procedure (knee/hip) with an anticipated stay of ≥48 hours
Adults ≥ 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and 1- and 3-months after surgery
Awards & highlights

SLEEP-BOOST Trial Summary

This trial aims to improve the sleep quality of older patients undergoing major joint surgery by using a mobile app and wearable device that have been previously tested for treating insomnia.

Who is the study for?
This trial is for older adults undergoing major joint surgery who may have sleep issues like insomnia or are at risk of postoperative cognitive complications. Participants should be willing to use a mobile app paired with a wearable device.Check my eligibility
What is being tested?
The study tests if digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) via an app, along with wearing a wrist device that tracks activity, can improve brain health outcomes after surgery compared to just receiving sleep health education.See study design
What are the potential side effects?
Since the interventions involve non-invasive therapy and education, side effects are minimal but could include discomfort from wearing the wrist device or stress from changing sleep habits.

SLEEP-BOOST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a knee or hip replacement and will stay in the hospital for at least 2 days.
Select...
I am 65 years old or older.
Select...
I have trouble sleeping, as confirmed by a test.

SLEEP-BOOST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and 1- and 3-months after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and 1- and 3-months after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence
Insomnia Severity
Secondary outcome measures
Anxiety
Cognition
Delayed Neurocognitive Recovery
+11 more
Other outcome measures
Circadian Rest-Activity Rhythms

SLEEP-BOOST Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Digital CBT-IExperimental Treatment1 Intervention
Preoperative digital CBT-I with the CBT-I Coach app and up to 4 weekly sessions
Group II: Sleep Health EducationActive Control1 Intervention
Preoperative sleep health education materials

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,936 Previous Clinical Trials
13,198,673 Total Patients Enrolled
12 Trials studying Insomnia
822 Patients Enrolled for Insomnia
Lei Gao, MDPrincipal InvestigatorMass. General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"Information available on clinicaltrials.gov indicates that recruitment for this particular trial is currently not ongoing. Despite being first posted on October 31, 2024 and having its latest update on April 16, 2024, the study is presently inactive in terms of patient enrollment. However, it's worth noting that there are a total of 291 active trials actively seeking participants at this time."

Answered by AI

What is the primary goal of this medical study?

"The primary aim of this clinical trial is to evaluate the impact of dCBT-I intervention on Insomnia Severity shortly before surgery, during a review session lasting approximately 3 days to 1 week. Secondary endpoints comprise assessing patient Satisfaction with the intervention through a comprehensive survey gauging app effectiveness and likelihood for recommendation to acquaintances or relatives, evaluating Cognition using the tMoCA test via telephone interaction, and monitoring Postoperative Neurocognitive Disorders (NCD) by measuring cognitive alterations from baseline data (equivalent to 1 standard deviation from the mean)."

Answered by AI
~33 spots leftby May 2026